BOPA Abstract deadline EXTENDED TO 9am Monday 10th August 2020

You spoke – we listened

The deadline for abstracts for this year’s virtual conference has been extended. Delegates are invited to present results of their clinical and technical work as a poster with some selected for oral presentation. The author/s should submit via the BOPA website by 9am Monday 10th August 2020. Abstracts will be reviewed and marked by the BOPA Audit and Research Sub-Committee, and chosen authors will be invited to display their poster for the duration of the conference, with the posters achieving high scores selected for oral presentation.

Selected abstracts will be published in a supplement to the Journal of Oncology Pharmacy Practice (JOPP), providing authors with a citation in a peer reviewed journal. The winning presentation will receive a prize worth £2,000 to attend an international conference.

Further information can be found on the abstract section of the website HERE.

Late Breaking Abstracts: This year we will allow delegates to submit late breaking abstracts. Abstracts relating to the Covid-19 pandemic will be considered for presentation by the research committee if completed work is submitted after the 10th August deadline. Please contact the A&R committee to request a late submission relating to Covid-19.

Latest News

By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article
By BOPA Executive Committee on 24th August 2026

BOPA 2026 Executive Committee Election – Have you cast your vote for your candidates?

Have you cast your vote for the 2026 BOPA Executive Committee Election? In 2026 we received 9 nominations for 6 positions. -Standard Committee Member (6 places available) – VOTING FOR…

Read article